References
- Richardson G S, Scully R E, Nikrui N, et al. Common epithelial cancer of the ovary. N Engl J Med 1985; 312: 415–424; 474–483
- Louie K G, Ozols R F, Myer C E, et al. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol 1986; 4: 1579–1585
- Dedrick R L, Myers C E, Bungay P M, et al. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 1978; 62: 1–11
- Howell S B, Pfeifle C E, Wang W E, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845–851
- Pretorius R G, Hacker N F, Berek J S, et al. Pharmacokinetics of ip cisplatin in refractory ovarian carcinoma. Cancer Treat Rep 1983; 67: 1085–1092
- Kaplan R A, Markman M, Lucas W E, et al. Infectious peritonitis in patients receiving intraperitoneal chemotherapy. Am J Med 1985; 78: 49–53
- Pfeifle C E, Howell S B, Markman M, et al. Totally implantable system for peritoneal access. J Clin Oncol 1984; 2: 1277–1280
- Young J A, Segler S. Outpatient cisplatin chemotherapy in a community hospital cancer center. J Okla St Med Soc 1985; 80: 343–346
- Markman M, Cleary S, Lucas W E, et al. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity. J Clin Oncol 1985; 3: 925–931
- McVie J G, ten Bokkel Huinink W W, Aartsen E, et al. Intraperitoneal chemotherapy in minimal residual ovarian cancer with cisplatin and sodium thiosulfate protection (abstr). Proc Am Soc Clin Oncol 1985; 4: 125
- Ozols R F, Ostchega Y, Myers C E, et al. Cisplatin in hypertonic saline in refractory ovarian cancer. J Clin Oncol 1985; 3: 1246–1250
- Levin L, Hryniuk W. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 1987; 5: 756–767
- Vogl S E, Farragi D, Kaplan B H. Dose-response relations for cisplatinum chemotherapy in metastatic ovarian cancer (abstr). Proc Am Soc Clin Oncol 1985; 4: 123